Deborah Middleton Selected Research

Henipavirus Infections

1/2017	Circulating microRNA profiles of Hendra virus infection in horses.
10/2016	Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion.
10/2013	A treatment for and vaccine against the deadly Hendra and Nipah viruses.
4/2013	Promotion of Hendra virus replication by microRNA 146a.
3/2013	Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets.
11/2009	Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.
10/2009	A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.
9/2007	Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat.
12/2006	Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deborah Middleton Research Topics

Disease

19	Infections 01/2020 - 01/2006
9	Henipavirus Infections 01/2017 - 12/2006
7	Human Influenza (Influenza) 05/2017 - 08/2009
3	Influenza in Birds (Avian Flu) 05/2017 - 03/2007
3	Viremia 01/2017 - 01/2012
2	Virus Diseases (Viral Diseases) 01/2012 - 11/2011
1	Newcastle Disease 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2014
1	Encephalitis (Encephalitis, Rasmussen) 01/2012
1	Malaria 11/2009
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2005

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2017 - 03/2007
4	Glycoproteins (Glycoprotein)IBA 10/2013 - 12/2006
3	MicroRNAs (MicroRNA)IBA 01/2017 - 04/2013
3	Antiviral Agents (Antivirals)IBA 01/2016 - 01/2012
3	Oseltamivir (Tamiflu)FDA Link 01/2016 - 09/2010
3	Monoclonal AntibodiesIBA 10/2013 - 12/2005
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2006
2	EpitopesIBA 01/2017 - 12/2005
2	Viral RNAIBA 06/2014 - 12/2012
2	AntigensIBA 06/2014 - 10/2012
2	Subunit VaccinesIBA 08/2011 - 12/2006
1	Messenger RNA (mRNA)IBA 01/2020
1	Chemokine CXCL10IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2017
1	Circulating MicroRNAIBA 01/2017
1	NucleotidesIBA 03/2013
1	Nucleocapsid ProteinsIBA 01/2012
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2012
1	Neutralizing AntibodiesIBA 01/2012
1	Interferon Type IIBA 01/2012
1	Viral AntigensIBA 01/2012
1	RestonIBA 11/2011
1	Neuraminidase (Sialidase)IBA 09/2010
1	Zanamivir (Relenza)FDA Link 09/2010
1	Pharmaceutical PreparationsIBA 09/2010
1	Chloroquine (Aralen)FDA LinkGeneric 11/2009
1	ISCOMATRIXIBA 08/2009
1	ElementsIBA 09/2007
1	Inactivated VaccinesIBA 03/2007
1	Biological ProductsIBA 01/2006
1	PrionsIBA 12/2005
1	Amino Acids FDA Link 12/2005
1	Prion ProteinsIBA 12/2005

Therapy/Procedure

4	Therapeutics 10/2016 - 11/2009